1. Ledergor, G., Weiner, A., Zada, M. et al. (2018). Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat Med 24, 1867-1876. [
DOI:10.1038/s41591-018-0269-2]
2. Gracia-Maldonado G, Clark J, Burwinkel M, et al ., (2022). LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia. Haematologica.; 107(4):803-815. [
DOI:10.3324/haematol.2020.257451]
3. Gracia-Maldonado, G., Clark, J., Pierre, P., et al ., (2018). The Role of LAMP5 in Innate Immune Signaling Is Critical for the Survival of MLL Leukemias. Blood, 132, 3900. [
DOI:10.1182/blood-2018-99-120190]
4. Rajkumar, S., Dimopoulos, M., Palumbo, A. (2014). International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma. The Lancet Oncology, 15(12), e538-548. [
DOI:10.1016/S1470-2045(14)70442-5]
5. Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, et al., (2015). Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 10;33(26):2863-9. [
DOI:10.1200/JCO.2015.61.2267]
6. Martin W. Schoen, Suhong Luo, Brian Gage, Kenneth Robert Carson, Kristen Marie Sanfilippo, (2018). Journal of Clinical Oncology, 36:15_suppl, 8051-8051. [
DOI:10.1200/JCO.2018.36.15_suppl.8051]
7. Harousseau, J. L., Attal, M., & Avet-Loiseau, H.et al ., (2009). The role of complete response in multiple myeloma. Blood, The Journal of the American Society of Hematology, 114(15), 3139-3146 [
DOI:10.1182/blood-2009-03-201053]
8. de Larrea C. F., Tovar N., Rozman M et al ., (2011). Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression. Biology of blood transplantation, 17(7), 1084-1087. [
DOI:10.1016/j.bbmt.2010.12.707]
9. Harousseau, J. L., Attal, M., & Avet-Loiseau, H.et al ., (2009). The role of complete response in multiple myeloma. Blood, The Journal of the American Society of Hematology, 114(15), 3139-3146. [
DOI:10.1182/blood-2009-03-201053]
10. Umeda S, Kanda M, Shimizu D, et al., (2022). Lysosomal associated Membrane Protein Family Member 5 Promotes the Metastatic Potential of Gastric Cancer Cells. Gastric Cancer; 25(3):558-72. [
DOI:10.1007/s10120-022-01284-y]
11. Chen, Y., & Ma, T. (2023). LAMP5 may promote MM progression by activating p38. Pathology and Oncology Research, 29, 1611083. [
DOI:10.3389/pore.2023.1611083]
12. Wang, H., Rueda, L. Y. M., Dang, M., Lee, et al ., (2023). Lysosomal Associated Membrane Protein Family Member 5 (LAMP5) As a Novel Mediator of, and Target in High Risk Multiple Myeloma (MM). Blood, 142, 873. [
DOI:10.1182/blood-2023-189286]